<SEC-DOCUMENT>0001193125-15-322187-index.html : 20150917
<SEC-HEADER>0001193125-15-322187.hdr.sgml : 20150917
<ACCEPTANCE-DATETIME>20150917122344
ACCESSION NUMBER:		0001193125-15-322187
CONFORMED SUBMISSION TYPE:	F-1/A
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20150917
DATE AS OF CHANGE:		20150917

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nabriva Therapeutics AG
		CENTRAL INDEX KEY:			0001641640
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C4
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		F-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-205073
		FILM NUMBER:		151111759

	BUSINESS ADDRESS:	
		STREET 1:		LEBERSTRASSE 20
		CITY:			VIENNA
		STATE:			C4
		ZIP:			1110
		BUSINESS PHONE:		43 (0)1 740 93-0

	MAIL ADDRESS:	
		STREET 1:		LEBERSTRASSE 20
		CITY:			VIENNA
		STATE:			C4
		ZIP:			1110
</SEC-HEADER>
<DOCUMENT>
<TYPE>F-1/A
<SEQUENCE>1
<FILENAME>d912889df1a.htm
<DESCRIPTION>FORM F-1 (AMENDMENT NO. 4)
<TEXT>
Document 1 - file: d912889df1a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>d912889dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 2 - file: d912889dex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g912889g32b53.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: g912889g32b53.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g912889g52e70.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: g912889g52e70.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g912889g67a59.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g912889g67a59.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g912889g94d16.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: g912889g94d16.jpg

</DOCUMENT>
</SEC-DOCUMENT>